FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Luitpold Petitions FDA for Requirements on Iron Products

[ Price : $8.95]

A just-posted citizen petition from Luitpold Pharmaceuticals requests that FDA require that any NDA for injectable iron for treati...

Senate Passes Compounding/Track and Trace Bill

[ Price : $8.95]

The U.S. Senate passes and sends on to the President legislation on drug compounding safety which included track and trace drug su...

Comments Sought on Special Protocol Assessment Info

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on information collection in the guidance on special protocol assessment.

Sanofi Scraps Cancer Therapy Due to Safety Concerns

[ Price : $8.95]

Sanofi decides to cancel the development of its investigational JAK2 inhibitor SAR302503 (fedratinib) due to safety concerns.

FDA Updates Form 356h and Form 2253

[ Price : $8.95]

FDA releases updated FDA Form-356h and FDA Form-2253, as well as accompanying instructions.

FDA Revises Draft Guidance on Drug Name Placement in Ads

[ Price : $8.95]

FDA revises a draft guidance to clarify requirements for product name placement, size, prominence, and frequency in promotional la...

FDA Rejects Ventripoint 510(k) for Hypertension Device

[ Price : $8.95]

FDA denies clearance of a Ventripoint Diagnostics 510(k) for its Ventripoint Medical Systems use in pulmonary aterial hypertension...

Woodcock Slashes ANDA Sponsor Communications

[ Price : $8.95]

CDER director Janet Woodcock tells a congressional hearing that the Office of Generic Drugs has shut down most communications with...

Hearing on Eyewash Product Rescheduled

[ Price : $8.95]

Federal Register Notice: FDA reschedules a public hearing on OTC emergency use eyewash products.

Scleral Plug into Class 2

[ Price : $8.95]

Federal Register Final rule: FDA classifies the scleral plug into Class 2 with special controls and is exempting the scleral plugs...